These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32003141)

  • 1. The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial.
    Okeke Ogwulu CB; Goranitis I; Devall AJ; Cheed V; Gallos ID; Middleton LJ; Harb HM; Williams HM; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Deb S; Duncan WC; Ewer AK; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden M; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Coomarasamy A; Roberts TE
    BJOG; 2020 May; 127(6):757-767. PubMed ID: 32003141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.
    Coomarasamy A; Harb HM; Devall AJ; Cheed V; Roberts TE; Goranitis I; Ogwulu CB; Williams HM; Gallos ID; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Crosfill F; Deb S; Duncan WC; Ewer A; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden MA; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Middleton LJ
    Health Technol Assess; 2020 Jun; 24(33):1-70. PubMed ID: 32609084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.
    Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Atik RB; Bloemenkamp KW; Brady R; Briley A; Cavallaro R; Cheong YC; Chu J; Eapen A; Essex H; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Parrott S; Ross JA; Sharpe L; Stewart J; Trépel D; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
    Health Technol Assess; 2016 May; 20(41):1-92. PubMed ID: 27225013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.
    Coomarasamy A; Devall AJ; Brosens JJ; Quenby S; Stephenson MD; Sierra S; Christiansen OB; Small R; Brewin J; Roberts TE; Dhillon-Smith R; Harb H; Noordali H; Papadopoulou A; Eapen A; Prior M; Di Renzo GC; Hinshaw K; Mol BW; Lumsden MA; Khalaf Y; Shennan A; Goddijn M; van Wely M; Al-Memar M; Bennett P; Bourne T; Rai R; Regan L; Gallos ID
    Am J Obstet Gynecol; 2020 Aug; 223(2):167-176. PubMed ID: 32008730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone for women with threatened miscarriage (STOP trial): a placebo-controlled randomized clinical trial.
    McLindon LA; James G; Beckmann MM; Bertolone J; Mahomed K; Vane M; Baker T; Gleed M; Grey S; Tettamanzi L; Mol BWJ; Li W
    Hum Reprod; 2023 Apr; 38(4):560-568. PubMed ID: 36806843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy.
    Coomarasamy A; Devall AJ; Cheed V; Harb H; Middleton LJ; Gallos ID; Williams H; Eapen AK; Roberts T; Ogwulu CC; Goranitis I; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Crosfill F; Deb S; Duncan WC; Ewer A; Hinshaw K; Holland T; Izzat F; Johns J; Kriedt K; Lumsden MA; Manda P; Norman JE; Nunes N; Overton CE; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingam N; Watkins L; Wykes C; Horne A; Jurkovic D
    N Engl J Med; 2019 May; 380(19):1815-1824. PubMed ID: 31067371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestogen for preventing miscarriage.
    Haas DM; Ramsey PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD003511. PubMed ID: 24173668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial.
    Okeke Ogwulu CB; Williams EV; Chu JJ; Devall AJ; Beeson LE; Hardy P; Cheed V; Yongzhong S; Jones LL; La Fontaine Papadopoulos JH; Bender-Atik R; Brewin J; Hinshaw K; Choudhary M; Ahmed A; Naftalin J; Nunes N; Oliver A; Izzat F; Bhatia K; Hassan I; Jeve Y; Hamilton J; Debs S; Bottomley C; Ross J; Watkins L; Underwood M; Cheong Y; Kumar CS; Gupta P; Small R; Pringle S; Hodge FS; Shahid A; Horne AW; Quenby S; Gallos ID; Coomarasamy A; Roberts TE
    BJOG; 2021 Aug; 128(9):1534-1545. PubMed ID: 33969614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestogen for preventing miscarriage.
    Oates-Whitehead RM; Haas DM; Carrier JA
    Cochrane Database Syst Rev; 2003; (4):CD003511. PubMed ID: 14583982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of progestogen for women with threatened miscarriage: a systematic review and meta-analysis.
    Li L; Zhang Y; Tan H; Bai Y; Fang F; Faramand A; Chong W; Hai Y
    BJOG; 2020 Aug; 127(9):1055-1063. PubMed ID: 32324957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestogen for preventing miscarriage.
    Haas DM; Ramsey PS
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003511. PubMed ID: 18425891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis.
    Eddama O; Petrou S; Regier D; Norrie J; MacLennan G; Mackenzie F; Norman JE
    Int J Technol Assess Health Care; 2010 Apr; 26(2):141-8. PubMed ID: 20392316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and cost effectiveness of vaginal progesterone gel in reducing preterm birth: an economic analysis of the PREGNANT trial.
    Pizzi LT; Seligman NS; Baxter JK; Jutkowitz E; Berghella V
    Pharmacoeconomics; 2014 May; 32(5):467-78. PubMed ID: 24715602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.
    Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J;
    Lancet; 2016 May; 387(10033):2106-2116. PubMed ID: 26921136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages.
    Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Bender Atik R; Bloemenkamp KW; Brady R; Briley AL; Cavallaro R; Cheong YC; Chu JJ; Eapen A; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Ross JA; Sharpe L; Stewart J; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
    N Engl J Med; 2015 Nov; 373(22):2141-8. PubMed ID: 26605928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.
    Kuptarak A; Phupong V
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2333929. PubMed ID: 38570191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
    Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
    BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of progesterone in pregnancy complications].
    van der Hoorn MP; Lashley EELO
    Ned Tijdschr Geneeskd; 2019 Oct; 163():. PubMed ID: 31682091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
    Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S
    Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.